S. 1058: Preserving Patient Access to Home Infusion Act

S. 1058 would rewrite Medicare's home infusion benefit so payment better matches how home treatment actually happens.

Right now, Medicare's rules can leave providers unpaid for key work that happens outside an in-home visit. This bill adds pharmacy services, assessments, drug preparation and compounding, care coordination, and documentation to the covered home infusion service.

It also changes how payment works. On days you receive an infusion drug at home but no clinician is physically present, Medicare would still pay suppliers 50% of the normal in-home rate.

For 2026 through 2029, the bill tells the Health and Human Services secretary to set the daily payment amount using a 5-hour infusion assumption. That gives suppliers a more predictable payment floor during the transition.

S. 1058 also expands who can approve and review your plan of care. Nurse practitioners and physician assistants—not just physicians—could handle that role.

The bill separately extends home infusion service payment to certain IV antibacterial, antifungal, and antiviral drugs that are not delivered through a pump. That means some patients using non-pump anti-infective drugs at home could still trigger Medicare payment for the related infusion services, even if the drug itself is not payable under Part B.

To offset some overlap, the bill stops separate payment for certain same-day supplies—like tubing, catheters, dressings, needles, and syringes—when Medicare is already paying for the home infusion therapy service tied to that drug on that day.